Results 121 to 130 of about 3,127 (197)

Phase I safety, efficacy, and biomarker response evaluations of three oral PD-L1 inhibitors: INCB086550, INCB099280, and INCB099318. [PDF]

open access: yesJ Immunother Cancer
Prenen H   +21 more
europepmc   +1 more source

A precision medicine approach to interpret a GATA4 genetic variant in a paediatric patient with congenital heart disease. [PDF]

open access: yesHum Genomics
Forbes CA   +10 more
europepmc   +1 more source

Can topical coconut oil reduce late-onset sepsis in extremely preterm infants? A pragmatic cluster-randomised controlled trial protocol. [PDF]

open access: yesBMJ Open
Strunk T   +9 more
europepmc   +1 more source

Complete genome sequence of <i>Burkholderia cenocepacia</i> bacteriophage Karil-mokiny-1. [PDF]

open access: yesMicrobiol Resour Announc
Canning JS   +6 more
europepmc   +1 more source

Clinical insights into the management of sleep disturbances within cancer care: a qualitative analysis. [PDF]

open access: yesSupport Care Cancer
Adams S   +5 more
europepmc   +1 more source

Immunotherapy rechallenge after significant toxicity - can it be done successfully? [PDF]

open access: yesImmunotherapy
Tan A   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy